93 7477 (Mycophenolate mofetil 500 mg)

Pill imprint 93 7477 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; systemic lupus erythematosus; uveitis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7477

Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil 500 mg 93 7477
Mycophenolate mofetil
Imprint:
93
7477
Strength:
500 mg
Color:
Purple
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7477
Inactive Ingredients:
croscarmellose sodium
FD&C Blue No. 2
aluminum oxide
FD&C Red No. 40
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
povidone k30
magnesium silicate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)